13D/13G Filings - JK BioPharma Solutions Inc

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-09-23
4:20 pm
Sale
2022-09-13 13D NeuroBo Pharmaceuticals, Inc.
NRBO
JK BioPharma Solutions Inc 0
0.000%
-10,908decrease
(Position Closed)
Filing
History
2021-11-10
2:17 pm
Unchanged
2021-10-05 13D NeuroBo Pharmaceuticals, Inc.
NRBO
JK BioPharma Solutions Inc 10,908
9.800%
0
(Unchanged)
Filing
History